Evidence map›Paper›PMID 18319712›Full record

SynthesisThe pharmacogenomics journal2009

Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives.

P E H Schwarz, G W Towers, A van der Merwe, L Perez-Perez, P Rheeder, J Schulze, S R Bornstein, J Licinio, M-L Wong, A E Schutte and 1 more

Abstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in The pharmacogenomics journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

P E H SchwarzDivision of Endocrinology, Department of Medicine III, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany. peter.schwarz@uniklinikum-dresden.de
G W Towers
A van der Merwe
L Perez-Perez
P Rheeder
J Schulze
S R Bornstein
J Licinio
M-L Wong
A E Schutte
A Olckers
North-West University · ZAUniversity Hospital Carl Gustav Carus · DEUniversity of Miami · USUniversity of Pretoria · ZA

Funding

Clinical Neuroendocrinology of LeptinK24RR016996 · NCRR · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LICINIO, JULIO · 2002 to 2006
$662k
NCRR NIH HHS K24 RR016996
6 · The paper itself

Abstract

Type II diabetes mellitus is currently globally one of the fastest growing non-communicable diseases, especially in developing countries. This investigation reports on a meta-analysis undertaken of the C-11377G locus within the adiponectin gene in a black South African, a Cuban Hispanic and a German Caucasian cohort. Genotyping was performed via a real-time PCR strategy. Both fixed- and random-effects models were tested to describe the diabetes risk at both the cohort and population levels. The 2,2 genotype may only be associated with increased diabetes risk in the Cuban Hispanic cohort. Population-specific effects may have masked these associations upon meta-analytical analysis, as no significant odds ratio could be determined. Thus, to examine diabetes risk, a more global approach including the design of population-specific experimental strategies should be used, which will be crucial in developing health education and policies in a global health programme.

Indexed as

Polymorphism, Single NucleotideAdiponectinAdultAfrica, SouthernBlack PeopleCohort StudiesCubaDiabetes Mellitus, Type 2FemaleGenetic Predisposition to DiseaseGenetics, PopulationGenetic TestingGenotypeGermanyHumansMaleAdiponectinADIPOQ protein, human

Identifiers

PMID18319712
OpenAlexW2094249344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.